Advanced Filters
noise
Found 1,216 clinical trials
D Deepak C D'Souza, MD

Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

The goal of this phase 1 study is to investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls. We hypothesize that administration of DMT will result in decreases in depression, associated symptoms, and neuroplastic changes in depressed subjects. We expect that DMT will induce …

21 - 65 years of age All Phase 1
L Lance Starzyk, BAAS AA

A Computerized Depression Intervention in Veterans

Depressive symptoms are common among Veterans and associated with significant impairment. Timely intervention has the potential to improve mental health outcomes and restore functioning. Interventions delivered through the internet can be completed remotely at any time, and thus minimize burden on Veterans, however the research examining their utility in Veterans …

18 years of age All Phase N/A
X Xiaoling Xiang, PhD

Empower@Home: Community Implementation for Older Adults With Ambulatory Disabilities

This study is a randomized Type I hybrid effectiveness-implementation trial aimed at evaluating the effectiveness of Empower@Home, an internet-delivered cognitive-behavioral therapy (CBT) program supported by social service providers, in comparison to enhanced usual care for depression in older adults with ambulatory disabilities. A total of 64 participants with ambulatory disabilities …

50 years of age All Phase N/A
D Devang Sanghavi, MD

A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients

The purpose of this research is to study the effects of intravenous ketamine infusions for the treatment of patients with depressive symptoms in intensive care unit (ICU).

18 - 99 years of age All Phase 2
Q Qianqian Xin

Improvement of Depression With Use of ATP

This clinical study is a randomized, double-blind, placebo-controlled trial with an intervention period of 4 weeks. Participants will be patients with moderate to severe depression who meet the inclusion criteria during the screening period. After recruitment written informed consent form will be signed and the baseline evaluation will be done …

18 - 65 years of age All Phase N/A
J Joanne V Loewy, DA, LCAT, MT-BC

Assessment of Music Experiences in Navigating Depression Part 2

This study is again looking at the use of music and music therapy experiences in navigating depression. The researchers will provide 11 sessions of music therapy and half will be followed by recitals at the Third Street School Music Settlement where the kids enrolled in our study will observe and …

7 - 15 years of age All Phase N/A
J Joshua Brown, MD, PhD

Pharmacologic Augmentation of TMS for Depression With D-serine

The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce …

18 - 80 years of age All Phase 1
Y Young Kim-wan, PhD

Efficacy of Narrative Therapy for Older People With Depression

The research aims to investigate the efficacy of a narrative therapy group in reducing depressive symptoms among older people. This study adopts a mixed methods research design, involving both quantitative and qualitative approaches. In the quantitative study, a randomised controlled trial will compare a narrative therapy group with a waitlist …

60 years of age All Phase N/A
K Kangguang Lin, Ph.D; MD

Treating Loneliness In The Older Adult With Depression With tDCS

High loneliness is prevalent among older adults and is a significant risk factor for major depression and low recovery rates in patients. Current interventions for loneliness are limited. Previous research has demonstrated a link between loneliness, negative social emotions, and reduced resting-state functional connectivity in the lateral prefrontal cortex (LPFC) …

60 - 80 years of age All Phase N/A
R Reyhan Ilhan, MS.

Neurobiological and Genomic Predictors of Relapse in Depression

The goal of this observational study is to test whether the discontinuation of antidepressant medications for patients with depression can be decided after the normalization of biological parameters. The main questions it aims are: When patients with depression treated with antidepressants, does their brain activity also become normal? If so, …

18 - 65 years of age All Phase N/A

Simplify language using AI